
    
      A study of the PK, safety, and efficacy of IV buprenorphine in acute moderate to severe pain
      in male and female pediatric patients aged from birth to 6 years, inclusive, requiring
      continuous opioid analgesic treatment for at least 24 hours and up to 72 hours.
    
  